Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Prosensa Therapeutics BV

Home Clinical Trial Sponsors and OrganizationsProsensa Therapeutics BV

Prosensa Therapeutics BV

CLOSED

NetherlandsPrivate

Part of biomarin nederland bv

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

8

8 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

7

87.5%

Trial Status Distribution

Active, not recruiting

8

100.0%

Clinical Trials

Trials sponsored by this organization (8)

A study to test if PRO053 is safe and effective in people who suffer from Duchenne muscular dystrophy

Active, not recruiting

Sep 201542 participants

A study to test if multiple injections of PRO045 are safe and effective in people who suffer from Duchenne muscular dystrophy

Active, not recruiting

Jun 201545 participants

A study to test if PRO053 is safe and effective in people who suffer from Duchenne muscular dystrophy

Active, not recruiting

Aug 201342 participants

A study to test if PRO053 is safe and effective in people who suffer from Duchenne muscular dystrophy

Active, not recruiting

Mar 201342 participants

A study to test if multiple injections of PRO045 are safe and effective in people who suffer from Duchenne muscular dystrophy

Active, not recruiting

Feb 201345 participants

A phase I/IIa, open label, escalating dose, pilot study to assess the effect, safety, tolerability and pharmacokinetics of multiple subcutaneous doses of PRO044 in patients with Duchenne muscular dystrophy - ND

Active, not recruiting

Apr 201018 participants

A study to assess the effect and safety of multiple subcutaneous doses of drisapersen in patients with Duchenne Disease

Active, not recruiting

Jan 200812 participants

A study to assess the effect and safety of multiple subcutaneous doses of drisapersen in patients with Duchenne Disease

Active, not recruiting

Dec 200712 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials8
Approvals
News

Back to Organizations